-
Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and relate...
Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides.
N Engl J Med. 1989 Sep 14 ;321(11):726-38.
PubMed
-
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV repli...
Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.
Lancet. 1986 Mar 15 ;1(8481):575-80.
PubMed
-
Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcrip...
Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerases alpha, beta, and gamma by the 5'-triphosphates of carbovir, 3'-azido-3'-deoxythymidine, 2',3'-dideoxyguanosine and 3'-deoxythymidine. A novel RNA template for the evaluation of antiretroviral drugs.
J Biol Chem. 1991 Jan 25 ;266(3):1754-62.
PubMed
-
VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothe...
VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers.
Exp Hematol. 2010 Sep ;38(9):733-43. Epub 2010 May 12 .
PubMed
-
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resi...
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.
AIDS. 2000 Mar 10 ;14(4):357-66.
PubMed
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
See more...